Skip to content
LexBuild

Title 21, Part 329 — Nonprescription Human Drug Products Subject to Section 760 of the Federal Food, Drug, and Cosmetic Act

1 sections

Section 329.100
Postmarketing reporting of adverse drug events under section 760 of the Federal Food, Drug, and Cosmetic Act.